Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Henk Joos Appointed Managing Director of FlandersBio

Published: Wednesday, January 15, 2014
Last Updated: Wednesday, January 15, 2014
Bookmark and Share
Henk’s objective is to maximize the valorization of the potential worldwide with FlandersBio.

The Board of Directors of FlandersBio has announced the appointment of Henk Joos as the new Managing Director of organization.

FlandersBio is the industrial networking organization for the life sciences sector in Flanders, a dynamic non-profit, fee-based organization with currently more than 280 members.

Henk (°1958, Roeselare) studied biology at the University of Ghent, where he obtained his PhD in 1984, after which he took the INSEAD Young Management Programme. Henk was active at Plant Genetic Systems (PGS) for a decade; first as a researcher and then as a business development manager.

After that he occupied various international management positions at, among others, AgrEvo, Aventis Cropscience, Bayer Cropscience, D1 oils and QUINVITA. Between 2004 and 2006 Henk was also a member of the FlandersBio’s Board of Directors. Therefore he was closely involved in the establishment of the organization.

“We are very pleased that Henk is joining the FlandersBio team as its Managing Director”, says Patrik De Haes, chairman of the Board of FlandersBio. “With his many years’ experience in the biotech sector, Henk can further develop FlandersBio into an integrated network that unites all actors. Several Flemish companies were at the outset of the industrialization of the various areas of biotechnology in Europe. The current Flemish biotech sector can therefore rely on a broad experience and an exceptional potential in this fast evolving and challenging business. Henk’s objective is to maximize the valorization of this potential worldwide with FlandersBio”.

Henk Joos is looking forward to his new position: “I consider becoming the Managing Director of FlandersBio a great honour, also at this historic moment in the existence of the organization, which is celebrating its 10th anniversary in 2014! FlandersBio has developed into a fascinating and extremely varied platform. I consider it my personal task to set up a very directional supportive policy for the members of FlandersBio. With the cluster of the FlandersBio member companies, Flanders has a unique flagship to further develop its knowledge economy internationally”.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biocartis Strengthens Management Team with CCO
Ulrik Cordes has joined the company as Chief Commercial Officer.
Thursday, September 05, 2013
KU Leuven and FIT Biotech Enter Into a Worldwide License Agreement
Collaboration agreement for the development of novel immunotherapeutics.
Tuesday, July 30, 2013
PathoGenetix and Applied Maths Sign Agreement
Both Companies to integrate RESOLUTION™ Microbial Genotyping System with BioNumerics™ software suite.
Thursday, June 27, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!